Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person Thomas, RK

Class:Id	Person:1980015
_displayName	Thomas, RK
_timestamp	2011-11-08 19:26:23
created	[InstanceEdit:1980016] Rothfels, K, 2011-11-08
firstname	Roman K
initial	RK
surname	Thomas
(author)	[LiteratureReference:1982028] Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer [LiteratureReference:2008165] Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain [LiteratureReference:6802107] Somatic mutations affect key pathways in lung adenocarcinoma [LiteratureReference:9651979] Novel MEK1 mutation identified by mutational analysis of epidermal growth factor receptor signaling pathway genes in lung adenocarcinoma [LiteratureReference:9701773] ALK mutations conferring differential resistance to structurally diverse ALK inhibitors [LiteratureReference:9715247] Insights into ALK-driven cancers revealed through development of novel ALK tyrosine kinase inhibitors
[Change default viewing format]

No pathways have been reviewed or authored by Thomas, RK (1980015)